Log In
Print this Print this

Symbyax, olanzapine/fluoxetine

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionCombination of a monoaminergic receptor antagonist and a selective serotonin reuptake inhibitor (SSRI)
Molecular Target Monoamine receptors ; Serotonin (5-HT) receptor
Mechanism of ActionMonoaminergic receptor antagonist; Selective serotonin reuptake inhibitor (SSRI)
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today